Saugier-Veber P, Devergie A, Sulahian A, Ribaud P, Traore F, Bourdeau-Esperou H, Gluckman E, Derouin F
Laboratoire de Parasitologie-Mycologie, Hôpital Saint-Louis, Paris, France.
Bone Marrow Transplant. 1993 Aug;12(2):121-4.
Of 322 patients undergoing allogeneic BMT, 18 developed invasive pulmonary aspergillosis at a mean of 115 days post-transplant, with a mortality rate of 82%. Pulmonary localization was common but cerebral involvement was seen in 10 of 18 patients. The diagnosis was made ante mortem in 11 patients by direct examination of pathological samples or culture and A. fumigatus was the only species isolated. Specific antibodies were not demonstrated before or at the time of clinical symptoms and Aspergillus antigen was only seen in one patient a few days before death.
在322例接受异基因骨髓移植的患者中,18例在移植后平均115天发生侵袭性肺曲霉病,死亡率为82%。肺部定位常见,但18例患者中有10例出现脑部受累。11例患者在生前通过病理样本直接检查或培养做出诊断,分离出的唯一菌种是烟曲霉。在临床症状出现之前或之时未检测到特异性抗体,仅1例患者在死亡前几天检测到曲霉抗原。